Thymosin-ß4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma.
Mol Oncol
; 9(7): 1484-500, 2015 Aug.
Article
in En
| MEDLINE
| ID: mdl-25963741
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thymosin
/
Antineoplastic Combined Chemotherapy Protocols
/
Neuroblastoma
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Mol Oncol
Journal subject:
BIOLOGIA MOLECULAR
/
NEOPLASIAS
Year:
2015
Document type:
Article